Y-mAbs Therapeutics Inc (YMAB)
15.27
-0.23
(-1.48%)
USD |
NASDAQ |
Apr 30, 11:14
Y-mAbs Therapeutics Cash and Short Term Investments (Quarterly): 78.64M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 78.64M |
| September 30, 2023 | 86.57M |
| June 30, 2023 | 87.91M |
| March 31, 2023 | 92.63M |
| December 31, 2022 | 105.76M |
| September 30, 2022 | 114.53M |
| June 30, 2022 | 133.66M |
| March 31, 2022 | 156.72M |
| December 31, 2021 | 181.56M |
| September 30, 2021 | 215.73M |
| June 30, 2021 | 233.59M |
| March 31, 2021 | 252.27M |
| Date | Value |
|---|---|
| December 31, 2020 | 114.63M |
| September 30, 2020 | 131.27M |
| June 30, 2020 | 158.06M |
| March 31, 2020 | 185.77M |
| December 31, 2019 | 207.14M |
| September 30, 2019 | 98.19M |
| June 30, 2019 | 120.16M |
| March 31, 2019 | 134.24M |
| December 31, 2018 | 147.84M |
| September 30, 2018 | 163.29M |
| June 30, 2018 | 70.15M |
| December 31, 2017 | 90.48M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
78.64M
Minimum
Dec 2023
252.27M
Maximum
Mar 2021
144.99M
Average
131.27M
Median
Sep 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| The Cooper Companies Inc | 135.20M |
| Puma Biotechnology Inc | 95.94M |
| Humacyte Inc | 80.45M |
| Moderna Inc | 8.604B |
| NovaBay Pharmaceuticals Inc | 3.13M |